JP2023051961A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023051961A5 JP2023051961A5 JP2022200267A JP2022200267A JP2023051961A5 JP 2023051961 A5 JP2023051961 A5 JP 2023051961A5 JP 2022200267 A JP2022200267 A JP 2022200267A JP 2022200267 A JP2022200267 A JP 2022200267A JP 2023051961 A5 JP2023051961 A5 JP 2023051961A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl chain
- disease
- compound according
- compound
- mitochondrial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT109818 | 2016-12-29 | ||
| PT10981816 | 2016-12-29 | ||
| PCT/IB2017/058508 WO2018122789A1 (en) | 2016-12-29 | 2017-12-29 | Hydroxybenzoic acid derivatives, methods and uses thereof |
| JP2019530099A JP2020503280A (ja) | 2016-12-29 | 2017-12-29 | ヒドロキシ安息香酸誘導体、その方法および使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019530099A Division JP2020503280A (ja) | 2016-12-29 | 2017-12-29 | ヒドロキシ安息香酸誘導体、その方法および使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023051961A JP2023051961A (ja) | 2023-04-11 |
| JP2023051961A5 true JP2023051961A5 (enExample) | 2023-04-18 |
| JP7689690B2 JP7689690B2 (ja) | 2025-06-09 |
Family
ID=61074472
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019530099A Pending JP2020503280A (ja) | 2016-12-29 | 2017-12-29 | ヒドロキシ安息香酸誘導体、その方法および使用 |
| JP2022200267A Active JP7689690B2 (ja) | 2016-12-29 | 2022-12-15 | ヒドロキシ安息香酸誘導体、その方法および使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019530099A Pending JP2020503280A (ja) | 2016-12-29 | 2017-12-29 | ヒドロキシ安息香酸誘導体、その方法および使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11078222B2 (enExample) |
| EP (1) | EP3562830B1 (enExample) |
| JP (2) | JP2020503280A (enExample) |
| KR (1) | KR102750630B1 (enExample) |
| CN (1) | CN110114365B (enExample) |
| BR (1) | BR112019011303B1 (enExample) |
| CA (1) | CA3048966A1 (enExample) |
| WO (1) | WO2018122789A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021085906A1 (ko) * | 2019-10-30 | 2021-05-06 | 주식회사 퓨전바이오텍 | 미토콘드리아 표적 화합물 및 이를 포함하는 노화 관련 질환의 치료 또는 예방을 위한 조성물 |
| WO2023053059A1 (en) * | 2021-09-30 | 2023-04-06 | Universidade Do Porto | Antifouling compound, method and uses thereof |
| US20250312360A1 (en) * | 2022-05-13 | 2025-10-09 | Virginia Tech Intellectual Properties, Inc. | Mitochondrial antioxidant treatment for cask-linked neurodevelopmental disorders |
| KR20240040435A (ko) * | 2022-09-21 | 2024-03-28 | 울산과학기술원 | 미토콘드리아 표적 화합물을 유효성분으로 포함하는 망막 변성 치료용 약학적 조성물 |
| KR102894216B1 (ko) * | 2022-12-15 | 2025-12-18 | 울산과학기술원 | Trap-1 억제제 |
| CN116210697B (zh) * | 2023-03-02 | 2024-05-14 | 西北农林科技大学 | 反式肉桂酸在提高苹果树腐烂病抗性中的应用 |
| KR20250126454A (ko) * | 2024-02-16 | 2025-08-25 | 울산과학기술원 | 암 세포의 티오에스테라제 및 활성산소종에 의해 자가 조립 중합되는 단량체 및 이의 용도 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010126719A1 (en) * | 2009-04-27 | 2010-11-04 | Mcw Research Foundation, Inc. | Neuroprotective compounds and their use |
| GB201320636D0 (en) * | 2013-11-22 | 2014-01-08 | Medical Res Council | Compounds |
| CN109328062A (zh) * | 2016-03-08 | 2019-02-12 | 密执安大学评议会 | 小分子活性氧簇诱导剂和线粒体活性抑制剂 |
| CN109843896B (zh) * | 2016-10-14 | 2022-12-20 | 波尔图大学 | 羟基肉桂酸衍生物、方法及其用途 |
-
2017
- 2017-12-29 KR KR1020197016316A patent/KR102750630B1/ko active Active
- 2017-12-29 WO PCT/IB2017/058508 patent/WO2018122789A1/en not_active Ceased
- 2017-12-29 US US16/475,277 patent/US11078222B2/en active Active
- 2017-12-29 CN CN201780081193.XA patent/CN110114365B/zh active Active
- 2017-12-29 EP EP17835943.6A patent/EP3562830B1/en active Active
- 2017-12-29 JP JP2019530099A patent/JP2020503280A/ja active Pending
- 2017-12-29 BR BR112019011303-7A patent/BR112019011303B1/pt active IP Right Grant
- 2017-12-29 CA CA3048966A patent/CA3048966A1/en active Pending
-
2022
- 2022-12-15 JP JP2022200267A patent/JP7689690B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12329739B2 (en) | Isoflavonoid compounds and methods for the treatment of cancer | |
| JP2020503280A5 (enExample) | ||
| JP7689690B2 (ja) | ヒドロキシ安息香酸誘導体、その方法および使用 | |
| SG188610A1 (en) | Methods and compositions for treating lung cancer | |
| JP6824906B2 (ja) | 併用療法 | |
| US9850195B2 (en) | Aspirin derivatives and uses thereof | |
| US20260000629A1 (en) | Ferroptosis inhibitor | |
| AU2008229617A1 (en) | Method for inducing autophagy | |
| US20230233519A1 (en) | Combination therapies | |
| CN110198929A (zh) | 用于治疗真菌感染的组合物和方法 | |
| US20120238511A1 (en) | 2-deoxy-d-glucose formulations for prevention or treatment of neurodegenerative diseases | |
| JP2021533115A (ja) | 神経疾患またはミトコンドリア疾患の処置のための化合物 | |
| JP6484448B2 (ja) | 新規ｇｅｍ−ジヒドロペルオキシド化合物 | |
| JP2019535795A (ja) | 口腔感染症の処置のための組成物及び方法 | |
| US12447137B2 (en) | Composition for prevention, amelioration, or treatment of cancer | |
| US20090298868A1 (en) | Quinoline compounds as melanogenesis modifiers and uses thereof | |
| Abdou et al. | Metallo-organic Copper (II) Complex in Nano Size as a New Smart Therapeutic Bomb for Hepatocellular Carcinoma | |
| EP0910354A1 (en) | Antioxidant compounds | |
| EP3708563B1 (en) | Selenopsammaplin a and derivative thereof, preparation method therefor, and composition for preventing and treating cancer, containing same as active ingredients | |
| KR102741641B1 (ko) | 설포라판을 유효성분으로 포함하는 피부 질환의 예방, 개선 또는 치료용 조성물 | |
| US20140275280A1 (en) | Therapeutic uses of geranylgeranyl acetone and derivatives thereof | |
| KR102466024B1 (ko) | 암의 예방, 개선 또는 치료용 조성물 | |
| JP2005507869A (ja) | 特殊構造を持つ新規抗癌化合物の一群 | |
| JP4490536B2 (ja) | 脳血管障害に基づく疾患の予防又は治療薬 | |
| EP1720849A1 (fr) | Derives de pyranone utiles pour le traitement du cancer |